Update On Anca Associated Vasculitis

KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and Treatment

Update on ANCA-Associated Vasculitis

Emory Department of Medicine

Opportunities to Further Care in ANCA-Associated Vasculitis: GPA and MPA

Interview 9 - Updates in ANCA Associated vasculitis management through cases and collaboration

Arthritis Broadcast Network

Philip Seo, M.D., M.H.S. - Update on ANCA-associated Vasculitis

ERN-RITA & EUVAS webinar: Updated EULAR recommendations on ANCA Associated Vasculitis

ANCA-associated Vasculitis: Update Therapy 2023 - Prof. Dr. Alexandre Karras (Paris, France)

Current issues in ANCA associated vasculitis

ClevelandClinicCME

ANCA Associated Vasculitis (Anti-Neutrophil Cytoplasmic Antibody) - Causes, Pathophysiology, Types

Armando Hasudungan

Update on ANCA Associated Vasculitis

Planetary Health Academia

KDIGO 2024 ANCA Vasculitis Guideline: Reading Between the Lines

Diagnosing Severe Active ANCA-Associated Vasculitis: Importance of Clinical Assessment in GPA & MPA

Ep. 223 – Updates in ANCA Associated vasculitis management through cases and collaboration

Arthritis Consumer Experts

ANCA associated vasculitis: 2024 KDIGO updates.

Vision Loss with ANCA-Associated Vasculitis

Rheumatology Patient Education: ANCA-Associated Vasculitis

MassGeneralHospital

ANCA-associated GN: the Known and the Unknowns with Dr Andreas Kronbichler

Ottawa Nephrology

Monitoring Patients With ANCA-Associated Vasculitis

Cleveland Clinic

Mechanism of Disease: ANCA-associated vasculitis (AAV)

Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis with Dr. Peter Merkel